SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 84 filers reported holding SERES THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 2.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -57.1% | 1,000 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | +40.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -81.5% | 1,000 | -71.4% | 0.00% | – |
| Q3 2018 | $27,000 | +145.5% | 3,500 | +133.3% | 0.00% | – |
| Q2 2018 | $11,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2018 | $11,000 | -57.7% | 1,500 | -42.3% | 0.00% | – |
| Q4 2017 | $26,000 | -23.5% | 2,600 | +23.8% | 0.00% | – |
| Q3 2017 | $34,000 | +61.9% | 2,100 | +10.5% | 0.00% | – |
| Q2 2017 | $21,000 | +110.0% | 1,900 | +111.1% | 0.00% | – |
| Q1 2017 | $10,000 | +11.1% | 900 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | -18.2% | 900 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | -8.3% | 900 | +125.0% | 0.00% | – |
| Q2 2016 | $12,000 | +50.0% | 400 | +33.3% | 0.00% | – |
| Q1 2016 | $8,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |